Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial

scientific article published in December 2017

Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5414/CN109198
P932PMC publication ID5700455
P698PubMed publication ID29092739

P50authorIvan RychlíkQ61138620
Kai-Uwe EckardtQ77053619
P2093author name stringAmandine Perrin
Iain C Macdougall
David Van Wyck
Andreas H Bock
Fernando Carrera
Simon D Roger
Sylvain Larroque
Yvonne Meier
Carlo Gaillard
P2860cites workFerrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysisQ26822051
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemiaQ34041146
New insights into the regulation of iron homeostasisQ34516972
Individualized treatment for iron-deficiency anemia in adultsQ34866851
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patientsQ34885195
Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patientsQ35003742
Iron therapy for renal anemia: how much needed, how much harmful?Q35650627
Association of genetic variants with response to iron supplements in pregnancyQ35666115
Ferumoxytol for treating iron deficiency anemia in CKDQ36796801
Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.Q37042142
Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?Q37656315
The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationaleQ37668885
Total dose iron infusion: safety and efficacy in predialysis patients.Q40624923
Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron.Q50733265
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial.Q51035442
A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney DiseaseQ54989527
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKDQ81549416
Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysisQ81639422
Within-patient variation of hemoglobin and reticulocytes: implications for evaluating ESA responsiveness in dialysis patientsQ84307547
Analytical and biological variation in measures of anemia and iron status in patients treated with maintenance hemodialysisQ84575212
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patientsQ84611960
Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rateQ84778579
Chapter 2: Use of iron to treat anemia in CKDQ87393429
P433issue12
P921main subjectchronic renal insufficiencyQ736715
P304page(s)301-310
P577publication date2017-12-01
P1433published inClinical NephrologyQ15763520
P1476titleErythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial
P478volume88

Reverse relations

cites work (P2860)
Q88035892Ferric Carboxymaltose: A Review in Iron Deficiency
Q52633750Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia.
Q58700150Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease
Q57167424Intravenous Irons: From Basic Science to Clinical Practice
Q91798034Parenteral versus oral iron therapy for adults and children with chronic kidney disease
Q57030706Sucrosomial Iron: A New Generation Iron for Improving Oral Supplementation

Search more.